Abstract
Introduction

38
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by th to 75 th percentiles of the data, and were compared statistically using a 2-sample Kolmogorov-Smirnoff test.
prioritize a subset of the missense de novo variants and their associated genes, we therefore 118 pursued a variant-centric approach in which we examined patterns of variant impact across 119 functionally related groups of genes. Genes were grouped by ontology using GO2MSIG (Powell statistically (p = 6.95e-4, q = 0.037) and visibly biased to higher EA scores (Fig. 2B) . As a 134 control, the same process was repeated using all missense de novo variants from the matched 135 siblings; no pathways exhibited significant bias toward high functional impact (Fig. 2C ). For (A) Hierarchical clustering of significant pathways. For the 398 genes with missense mutations that were associated with at least one significant pathway, a matrix was created to denote whether the gene was (red) or was not (grey) a component of the pathway, and pathways were then grouped according to their patterns of affected genes via hierarchical clustering performed by GENE-E. (B) Evolutionary Action score distribution for 'Synaptic Transmission' pathway. Evolutionary Action scores for the proband variants and matched sibling variants in this pathway were binned in deciles and represented as histograms. (C) Significance of all tested pathways in patient versus matched sibling cohorts. Each point represents one of the 368 tested pathways, and is connected with a line to the same pathway in the matched cohort. The q = 0.1 significance threshold after FDR correction is represented as a dashed red line. (Fig. 3) . Relationship between predicted variant impact and clinical presentation for patient pairs affected by different de novo missense variants in the same candidate gene. Pairs of patients affected by different de novo missense variants in the same prioritized gene were identified across the 398 prioritized genes (n = 28). Within the pair, the patient with the higher variant EA score was determined, and the fullscale IQ scores of the higher-EA group were compared to the lower-EA patient group using a paired t-test. Correctly prioritized pairs are shown linked by a solid black line, while incorrectly prioritized pairs are shown linked by a dashed grey line.
140
To further explore the relationship between these variants and patient presentation, all male found between the three IQ groups, with the lowest IQ patient group having the highest impact 164 mutations in the prioritized genes (p = 0.048; Kruskal-Wallis test) (Fig. 4A) . This relationship 165 between IQ and mutation EA scores was not seen when applied to all genes affected by de novo 166 mutations (p = 0.58) or to genes that were not prioritized by the method (p = 0.89) (Fig. 4A) . Prioritized genes, deprioritized genes, and all genes with de novo missense variants were assessed for their relationship to patient IQ. For each male patient, the summed EA burden of de novo missense variants was calculated for each category, both without (A) and with (B) EA score weighting for genic intolerance to mutation. The patients were then split into three groups by their fullscale IQ score and the scores were compared using Kruskal-Wallis tests. Error bars reflect the 95% CI of the mean.
predictive of phenotypic severity ( Supplementary Fig. 2 ), adjusting the EA impact score to 172 account for differences in genic tolerance to mutation further improved the ability of the EA score 173 burden in prioritized genes to predict patient phenotype, and this relationship was significant both 174 when binned (p = 0.0028; Fig. 4B ) and unbinned (p = 0.013, linear regression) (Supplementary Table 3 ). In addition, this correlation was highly robust to the metric used to define genic 176 tolerance to mutation (Supplementary Table 4 ) and was significant also when verbal or non-also robust to the impact prediction method applied, though the strongest correlations between genotype and phenotype were consistently found using EA (Supplementary Table 6 Table 7 ).
187
Furthermore, while the EA score burden accounted for cases in which more than one 188 variant of interest was detected in a patient's exome, the results could not be explained by an 189 uneven distribution of patients affected by multiple de novo variants in prioritized genes (p = 190 0.51; chi square test) ( Supplementary Fig. 3A ), and the genotype-phenotype relationship impact profile across prioritized genes is equally biased to high action ( Supplementary Fig. 4A 
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Figure 5. Effect of SFARI curation confidence and prioritization status on the relationship between genotype and phenotype. For each of three gene sets of interest (All prioritized genes, prioritized genes overlapping with a SFARI 'Gold Standard' designation (SFARI categories 1-3), and prioritized genes without a SFARI confidence score), the gene set EA burdens of all male patients with at least one de novo missense variant within the gene set were averaged, and patients were split into 'Higher EA burden' and 'Lower EA burden' groups based on whether their score was above or below the average burden, respectively. Groups were compared statistically with an unpaired t-test, and the mean and 95% CI interval of the mean for each group is displayed overlaying all IQ scores for patients in the group.
We next re-performed the analyses with a more stringent definition of novelty, 226 comparing our prioritized gene set to an uncurated assessment of the current published literature.
227
We defined genes with at least one association in Pubmed between the gene name and the term 228 'autism' as being supported by the literature, and found that prioritized genes were significantly were assessed for their relationship to patient IQ. Male patients were then split into three groups by their full-scale IQ score and their weighted EA burdens were compared using Kruskal-Wallis tests. Error bars reflect the 95% CI of the mean. (D) de novo missense variants in deprioritized genes with literature support (n = 66) were assessed for their relationship to patient IQ as above. (E) For each of three gene sets of interest (All prioritized genes, prioritized genes with at least one Pubmed association to autism, and prioritized genes without a Pubmed association to autism), the gene set EA burdens of all male patients with at least one de novo missense variant within the gene set were averaged, and patients were split into 'Higher EA burden' and 'Lower EA burden' groups based on whether their score was above or below the average burden, respectively. Groups were compared statistically with an unpaired t-test, and the mean and 95% CI interval of the mean for each group is displayed overlaying all IQ scores for patients in the group.
correlates to phenotype severity patient presentation, we next tested whether rare inherited variations in these same genes 249 exhibited a similar relationship with IQ. We considered rare and low-frequency inherited variants 250 (MAF<0.05) that were detected in at least one parent, but were not inherited by the healthy 251 sibling. For each patient, we calculated the inherited EA burden in the candidate genes as the 252 summation of all EA scores in these variants after adjustment for gene-specific tolerance to 253 mutation. We found there was a significant correlation between IQ and inherited variant EA Relationship between inherited EA score burden and patient IQ for prioritized and deprioritized gene groups (A) For each male patient, rare and low-frequency inherited variants (MAF < 0.05) that were detected in at least one parent, but not inherited by the healthy sibling, were identified across prioritized genes and the inherited EA burden was calculated as the summation of all EA scores of these variants after weighting for genic tolerance to mutation. The line indicates the linear regression across all points and the shaded grey area represents the 95% CI; the p-value displayed corresponds to the significance of the regression. For visualization purposes, the patients were also sorted by IQ and divided into nine equal groups; the average burden and IQ of each group is overlaid upon the regression and error bars indicate the standard error of the mean. (B) Log(p-values) of the linear regression of IQ and inherited EA burden as the MAF threshold is increasingly restricted to lower frequencies, for prioritized genes, deprioritized genes, and lowerconfidence SFARI genes.
Discussion
263
Our data show for the first time that de novo missense impact signatures can be used to elucidate 264 causative pathways in a complex multigenic disease and prioritize variants that stratify disease 265 severity. Here, using sequencing data from 2,384 individuals diagnosed with autism, we 266 hypothesized that affected cohort-specific selection for large variant fitness effects within a group 267 of functionally related genes implied an association of those pathways and genes to ASD. We 
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To the best of our knowledge, this study is the first to directly link missense variant 
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Differentiation then leads to the EA equation: 
